SWP
EDIT icon

Stratos Wealth Partners’s Editas Medicine EDIT Stock Holding History

Stratos Wealth Partners’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-800
Closed -$25K – 1246
2018
Q3 		$25K Buy
+800
New +$25.9K ﹤0.01% 1770
2018
Q2 		– Sell
-600
Closed -$20K – 1385
2018
Q1 		$20K Hold
600
– – ﹤0.01% 2006
2017
Q4 		$18K Buy
+600
New +$15.1K ﹤0.01% 1947

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Stratos Wealth Partners's EDIT Position: Q4 2018 in Review

Stratos Wealth Partners sold out of Editas Medicine (EDIT) in Q4 2018, closing a stake of 800 shares — an estimated $25K sold.

Stratos Wealth Partners first reported a position in EDIT in Q4 2017 and held it in 3 quarters. The position peaked at $25K in Q3 2018. 194 funds tracked by Wall St. Rank hold EDIT as of Q4 2018.

  • Stratos Wealth Partners reported no remaining Editas Medicine position as of Q4 2018 after selling out during the quarter.
  • Stratos Wealth Partners sold 800 Editas Medicine shares in Q4 2018, an estimated $25K.
  • Stratos Wealth Partners first reported a position in Editas Medicine in Q4 2017 and held it in 3 quarters.
  • Stratos Wealth Partners's Editas Medicine position peaked at $25K in Q3 2018.
  • 194 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2018.

Based on Stratos Wealth Partners's 13F filing for Q4 2018, filed 8 Feb 2019.